| ID | Name | CAS | Properties |
logPoct/wat |
| 118-556-4 |
1,7-Di(2,5-dichlorophenyl)-2,2,4,4,6,6-hexamethyl-1,3,5,7-tetraoxa-2,4,6-trisilaheptane
|
|
2 | 7.897 |
| 118-560-9 |
2-Aminobenzoic acid, N- pentafluoropropionyl -, N,O-bis(tert.-butyldimethylsilyl)-
|
|
2 | 7.384 |
| 118-590-6 |
2H-benzo[a]quinolizine-3-carboxamide,n,n-diethyl-1,3,4,6,7,11b-hexahydro-2-hydroxy-9,10-dimethoxy-,methyl ester carbonate
|
|
2 | 2.643 |
| 118-593-3 |
1H-Indole-3-acetic acid, 1-(trimethylsilyl)-5-[(trimethylsilyl)oxy]-, trimethylsilyl ester
|
55268-67-2 |
2 | 5.459 |
| 118-652-7 |
D-(+)-Glucuronic acid «gamma»-lactone, tris(trimethylsilyl) ether, methyloxime (anti)
|
|
2 | 3.204 |
| 118-653-6 |
D-(+)-Glucuronic acid «gamma»-lactone, tris(trimethylsilyl) ether, methyloxime (syn)
|
|
2 | 3.204 |
| 118-989-4 |
Nigerotriose: aD-Glcp(1->3)-aDGlcp(1->3)-DGlc, oxime-TMS, isomer # 1
|
|
2 | 14.359 |
| 119-043-2 |
1,8-Dihydroxy-6-methoxy-3-methylanthraquinone, O,O'-bis(trimehylsilyl)
|
7336-75-6 |
2 | 5.206 |
| 119-048-7 |
2H-1,3-Benzoxazine, 6-chloro-3,4-dihydro-3-phenyl-
|
|
2 | 3.696 |
| 119-106-2 |
6'-Glucosyl-cellobiose: aD-Glcp(1->6)-bDGlcp(1->4)-DGlc, oxime-TMS, isomer # 2
|
|
2 | 14.359 |
| 119-222-3 |
15(S)-15-Methyl-PGD2, EO-TMS, isomer # 2
|
|
2 | 9.476 |
| 119-271-9 |
Octanoic acid, 2-[(tert-butyldimethylsilyl)oxy]-, tert-butyldimethylsilyl ester, (.+/-.)-
|
|
2 | 6.896 |
| 119-351-0 |
6'-Glucosyl-cellobiose: aD-Glcp(1->6)-bDGlcp(1->4)-DGlc, oxime-TMS, isomer # 1
|
|
2 | 14.359 |
| 119-366-4 |
4-Methylvaleric acid, dimethyl(3,3,3-trifluoropropyl)silyl ester
|
|
2 | 4.123 |
| 119-396-1 |
1,2-Cyclobutanedicarboximide, n-butyl-4-dimethylamino-3,3-dimethyl-
|
|
2 | 1.358 |
| 119-698-6 |
Benzoic acid, 2,3-bis[(tert-butyldimethylsilyl)oxy]-, tert-butyldimethylsilyl ester
|
|
2 | 8.617 |
| 119-751-6 |
3-Aminobenzoic acid, N- pentafluoropropionyl -, N,O-bis(tert.-butyldimethylsilyl)-
|
|
2 | 7.384 |
| 119-805-6 |
Talonic acid, 2,3,5,6-tetrakis-O-(trimethylsilyl)-, lactone
|
55515-31-6 |
2 | 4.424 |
| 119-884-9 |
Prosta-8(12),13-dien-1-oic acid, 9-(methoxyimino)-15-[(trimethylsilyl)oxy]-, trimethylsilyl ester
|
72150-31-3 |
2 | 8.155 |
| 119-927-1 |
Lactosucrose: bD-Galp(1->4)-aDGlcp(1->2)-bFru, oxime-TMS
|
|
2 | 12.837 |
| 120-000-7 |
Butanoic acid, 4,4'-dithiobis[2-[(trimethylsilyl)amino]-, bis(trimethylsilyl) ester, [S-(R*,R*)]-
|
69688-45-5 |
2 | 5.490 |
| 120-016-0 |
Nonanamide, N-[[3-methoxy-4-[(trimethylsilyl)oxy]phenyl]methyl]-8-methyl-
|
56784-16-8 |
2 | 5.522 |
| 120-048-5 |
15(S)-15-Methyl-PGD2, MO-TMS, isomer # 2
|
|
2 | 9.086 |
| 120-061-0 |
Adenosine, N-(trimethylsilyl)-2',3'-bis-O-(trimethylsilyl)-, 5'-[bis(trimethylsilyl) phosphate]
|
32653-14-8 |
2 | 7.238 |
| 120-166-4 |
6,11-Dihydro-6,11-dioxo-5a,12-diazabenzo[b] cycloheptano [a]-indene
|
97999-91-2 |
2 | 2.385 |
| 120-185-3 |
1,6-Dihydroxy-8-methoxy-3-methylanthraquinone, O,O'-bis(trimethylsilyl)-
|
91701-23-4 |
2 | 5.206 |
| 120-209-6 |
3«alpha»,5«beta»,7«alpha»,12«alpha»-tetrahydroxy-5«beta»-cholan-24-oic acid, DMESI
|
|
2 | 13.244 |
| 120-247-4 |
Androst-4-en-9«alpha»-fluoro-17«alpha»-methyl-3«alpha»,6«beta»,11«beta»,17«beta»-tetraol, TMS
|
|
2 | 9.532 |
| 120-248-3 |
6'-Galactosyl-lactose: bD-Galp(1->6)-bDGalp(1->4)-DGlu, oxime-TMS, isomer # 1
|
|
2 | 14.359 |
| 120-556-1 |
Silica-1,3,5,7-tetramethyl-2,4,6,8-tetraethylporphyrine complex, bis-OTMS
|
|
2 | 4.942 |
| 120-608-3 |
5-Pyrimidinecarboxylic acid, 2,4-bis[(trimethylsilyl)oxy]-, trimethylsilyl ester
|
56804-96-7 |
2 | 3.896 |
| 120-676-8 |
4,7,13,16-Tetraoxa-1,10-dithiacyclooctadecane-1,10-bis-p-tolyl-sulfonylimido- (beta-form)
|
|
2 | 3.065 |
| 120-685-8 |
d-Fructose, 1,3,4,5-tetrakis-O-(trimethylsilyl)-, o-methyloxime, 6-[bis(trimethylsilyl) phosphate]
|
55530-74-0 |
2 | 8.328 |
| 120-737-0 |
Androst-5-en-11-one, 3,17-bis[(trimethylsilyl)oxy]-, (3«beta»,17«beta»)-
|
49774-90-5 |
2 | 6.568 |
| 120-748-8 |
Pentanoic acid, 3-oxo-2-propyl, enol-bis-TMS, # 2
|
|
2 | 4.680 |
| 120-915-2 |
Methyl 5-.beta.-cholan-3-one-24-oate, oxime, TMS # 1
|
|
2 | 7.442 |
| 120-958-5 |
Methyl 5-.beta.-cholan-12-.alpha.-ol-3-one-24-oate, oxime, TMS # 2
|
|
2 | 8.272 |
| 121-049-3 |
3,5-Dioxa-4-phospha-2-silaheptan-7-oic acid, 2,2-dimethyl-4-[(trimethylsilyl)oxy]-6-[[(trimethylsilyl)oxy]methyl]-, trimethylsilyl ester, 4-oxide
|
|
2 | 5.412 |
| 121-103-2 |
Silane, dimethyl(dimethyl(but-2-enyloxy)silyloxy)(but-2-enyloxy)-
|
|
2 | 3.592 |
| 121-178-0 |
3-hydroxy-4-methylglutamic acid, N(O,S)-isoBOC TBDMS, diastreoisomer 2
|
|
2 | 6.400 |
| 121-196-0 |
2,4,6-trimethyl-2,4,6,8,8-pentaphenyl-[1,3,5,7,2,4,6,8]cyclotetrasiloxane
|
|
2 | 4.261 |
| 121-204-0 |
15(S)-15-Methyl-PGA2, BO-TMS, isomer # 2
|
|
2 | 9.203 |
| 121-258-1 |
Formebelone M (Androst-1,4-dien-2z-hydroxymethyl-17A-methyl-11A,17B-diol-3-one), TMS
|
|
2 | 9.732 |
| 121-276-1 |
Trimethylsilyl 2-amino-3-(3-chloro-4-[(trimethylsilyl)oxy]phenyl)propanoate
|
|
2 | 3.802 |
| 121-324-7 |
Piperazine, 1,4-bis-(2,3-epoxypropyl)-2,5-dimethyl-
|
|
2 | 0.179 |
| 121-411-0 |
Glycine, N-(3-methyl-1-oxo-2-butenyl)-, trimethylsilyl ester
|
|
2 | 1.447 |
| 121-508-3 |
2,2,4,4,6,8-hexamethyl-6,8-di(2-cyanoethyl)-[1,3,5,7,2,4,6,8]cyclotetrasiloxane
|
|
2 | 3.441 |
| 121-523-6 |
D-Mannose, 2,3,4,5-tetrakis-O-(trimethylsilyl)-, O-methyloxime, 6-[bis(trimethylsilyl) phosphate]
|
55530-76-2 |
2 | 8.327 |
| 121-528-1 |
5-Pregnan-11-one, 3«alpha»,20«alpha»,21-trihydroxy, TMSO-TMS
|
|
2 | 9.754 |
| 121-532-6 |
27-nor-5-«beta»-Cholestan-3-«alpha»,7-«alpha»,12-«alpha»,24,25-pentol, TMS, # 1
|
|
2 | 11.165 |
| 121-550-6 |
Silane, dimethyl(2,6-dimethylnon-1-en-3-yn-5-yloxy)isobutoxy-
|
|
2 | 4.762 |
| 121-552-4 |
Silane, dimethyl(dimethyl(non-5-yn-3-yloxy)silyloxy)isobutoxy-
|
|
2 | 5.068 |
| 121-562-3 |
3,20-Dioxo-11«beta»,18-epoxy-17«alpha»,18,21-trihydroxy-4-pregnene, MO-TMS, syn
|
|
2 | 7.562 |
| 121-580-3 |
«alpha»-D-Glucopyranose, 2,3,4,6-tetrakis-O-(trimethylsilyl)-, bis(trimethylsilyl) phosphate
|
55520-79-1 |
2 | 8.051 |
| 121-771-1 |
11«alpha»,15«alpha»-dihydroxy-9-ketoprosta-5,13-dienoic acid, 19-hydroxy, MO-TMS # 2
|
|
2 | 9.916 |
| 121-795-5 |
4-Pentenoic acid, 2-(1-oxopropyl), enol-bis-TMS, # 2
|
|
2 | 4.456 |
| 121-804-4 |
Pyrimidine, 2,4-dihydroxy-6-oxo-5,5-diethyl, TMS
|
|
2 | 3.790 |
| 121-884-6 |
Silane, [[(17«beta»)-androsta-3,5-diene-3,17-diyl]bis(oxy)]bis[(1,1-dimethylethyl)dimethyl-
|
64898-31-3 |
2 | 9.855 |
| 121-893-6 |
Benzeneacetic acid, 3-methoxy-«alpha»,4-bis[(trimethylsilyl)oxy]-, trimethylsilyl ester
|
|
2 | 5.180 |
| 121-980-9 |
5-Pregnan-11-one, 3«alpha»,20«alpha»,21-trihydroxy, EO-TMS
|
|
2 | 8.939 |
| 121-991-7 |
L-Tyrosine, N,O-bis(trimethylsilyl)-3-[(trimethylsilyl)oxy]-, trimethylsilyl ester
|
55638-45-4 |
2 | 5.828 |
| 122-004-1 |
13,14-Dihydro-15-keto-PGF1A, EO-TMS, isomer # 2
|
|
2 | 9.534 |
| 122-050-0 |
3«alpha»,7«alpha»,12«alpha»,25-tetrahydroxy-5«beta»-C27-bile acid, methyl ester, TMS
|
|
2 | 11.115 |
| 122-063-6 |
4-(2-Hydroxyethyl)-2,2-dimethyl-1,3-dioxolane, (3-cyanopropyl)dimethylsilyl ether
|
|
2 | 3.053 |
| 122-147-3 |
4,7,13,16-Tetraoxa-1,10-dithiacyclooctadecane-1,10-bis-p-tolyl-sulfonylimido- (alpha-form)
|
119698-57-6 |
2 | 3.065 |
| 122-177-0 |
11«alpha»,15«alpha»-dihydroxy-9-ketoprosta-5,13-dienoic acid, 19-hydroxy, EO-TMS # 2
|
|
2 | 10.307 |
| 122-220-1 |
1,3-Disiloxane, 1,3-dimethyl, 1,3-bis-(chloromethyl), 1,3-bis-(2-chloroethyl)
|
|
2 | 4.187 |
| 122-247-2 |
13,14-Dihydro-15-keto-PGF2A, EO-TMS, isomer # 2
|
|
2 | 9.310 |
| 122-275-1 |
Methyl 5-.beta.-cholan-7-.alpha.-ol-3-one-24-oate, oxime, TMS # 1
|
|
2 | 8.272 |
| 122-280-5 |
9-Oxo-11-octadecenoic acid, 13-hydroxy, PFBO, TMS, methyl ester, # 1
|
|
2 | 8.905 |
| 122-330-9 |
Phosphoric acid, 2-(trimethylsiloxy)-1-[(trimethylsiloxy)methyl]ethyl bis(trimethylsilyl) ester
|
|
2 | 5.886 |
| 122-337-2 |
N-(2-Hydroxy-1-phenyl-ethyl)-benzenesulfonamide, N,O-di(trimethylsilyl)-
|
|
2 | 5.105 |
| 122-388-6 |
2-Pyridinecarbamic acid, 4-(allylamino)-6-amino-5-nitro-, ethyl ester
|
|
2 | 1.738 |
| 122-427-2 |
1,3(5«beta»)-androsten-3,17«beta»-diol di-TMS
|
|
2 | 7.370 |
| 122-472-2 |
Disiloxane, 1,1,3,3-tetramethyl-1,3-bis(pentafluorophenyl)-
|
19091-32-8 |
2 | 4.619 |
| 122-595-6 |
1-Chloro-3-methoxy-propan-2-ol, tert-butyldimethylsilyl ether
|
|
2 | 3.262 |
| 122-663-0 |
2-[(3-Hydroxy-2,2,4,4-tetramethyl)cyclobutoxy]-3-methylpyrazine
|
|
2 | 1.959 |
| 122-731-4 |
13,14-Dihydro-15-keto-PGF2A, MO-TMS, isomer # 2
|
|
2 | 8.920 |
| 122-761-1 |
2,3-Dihydroxypropyl-(2-hydroxy-1-hydroxymethyl)ethylamine, tetrakis-TMS
|
|
2 | 4.719 |
| 122-820-5 |
Glycine, N-(2-methyl-1-oxo-2-butenyl)-N-(trimethylsilyl)-, trimethylsilyl ester, (E)-
|
55517-45-8 |
2 | 2.994 |
| 123-068-0 |
3H-naphth[1,2-d]imidazole, 3-(p-anisidino)-2-(p-methoxyphenyl)-
|
13847-93-3 |
2 | 5.749 |
| 123-128-3 |
Methyl 5-«beta»-cholan-3,7-dione-24-oate, oxime, TMS # 2
|
|
2 | 8.259 |
| 123-147-2 |
Silane, diphenylisohexyloxy(2,2,3,3,4,4,5,5-octafluoropentyloxy)-
|
|
2 | 5.883 |
| 123-195-9 |
Prosta-8(12),13-dien-1-oic acid, 9-oxo-15-[(trimethylsilyl)oxy]-, trimethylsilyl ester, (13E,15S)-
|
56009-41-7 |
2 | 7.721 |
| 123-212-9 |
trans-3-Hydroxycinnamic acid, tert-butyldimethylsilyl ether, tert-butyldimethylsilyl ester
|
|
2 | 6.632 |
| 123-363-2 |
tert-Butyl(dimethyl)silyl-2-{[tert-butyl(dimethyl)silyl]oxy}-3-(4-{[tert-butyl(dimethyl)silyl]oxy}phenyl)acrylate
|
|
2 | 8.982 |
| 123-605-3 |
Glycine, N-(trimethylsilyl)-N-[4-[(trimethylsilyl)oxy]benzoyl]-, trimethylsilyl ester
|
55517-55-0 |
2 | 4.556 |
| 123-845-7 |
1-«beta»,3-«alpha»,7-«alpha»,12-«alpha»-Tetrahydroxy-5-«beta»-cholanoic acid, MeTMS
|
|
2 | 9.945 |
| 123-904-1 |
4-Aminobenzoic acid, N,N-bis(acetyl)-, tert.-butyldimethylsilyl ester
|
|
2 | 3.748 |
| 123-926-7 |
2,4-dimethyl-2,4,6,6,8,8-hexaphenyl-[1,3,5,7,2,4,6,8]cyclotetrasiloxane
|
|
2 | 4.538 |
| 123-940-1 |
9,10-epoxy-18-hydroxyoctadec-12-enoic acid, TMSi ester TMSi ether
|
|
2 | 7.221 |
| 124-001-2 |
Pregnane-3,20-dione, 17-[(trimethylsilyl)oxy]-, bis(O-methyloxime), (5«beta»)-
|
57305-29-0 |
2 | 6.644 |
| 124-004-9 |
Urea,[4-(2-furylmethyl(methyl)amino)-2,2-diphenyl-n-butyl]-
|
|
2 | 3.756 |
| 124-083-2 |
5-Cholesten-3-«beta»,7-«alpha»,12-«alpha»,24,25-pentol, TMS, # 3
|
|
2 | 12.712 |
| 124-125-5 |
3,4-Dihydroxy-dl-phenylalanine, N,O,O'-tris(tert-butyldimethylsilyl)-, tert-butyldimethylsilyl ester
|
|
2 | 10.509 |
| 124-129-1 |
2-Aminobenzoic acid, N- trifluoroacetyl -, N,O-bis(tert.-butyldimethylsilyl)-
|
|
2 | 6.749 |
| 124-243-4 |
Androstan-16-one, 3-[(trimethylsilyl)oxy]-, O-methyloxime, (3«beta»,5«alpha»)-
|
57305-08-5 |
2 | 6.252 |
| 124-341-5 |
Trimethylsilyl 2-amino-4-oxo-4-pyrrol2-[(trimethylsilyl)amino]phenylmorphobutanoate
|
|
2 | 3.212 |
| 124-387-5 |
Cholan-24-oic acid, 3,7,12-tri(trimethylsilyloxy)-, trimethylsilyl ester, (3«alpha», 5«beta», 7«alpha», 12«alpha»)-
|
|
2 | 10.320 |
| 124-493-7 |
Adenosine, 5'-S-methyl-5'-thio-N-(trimethylsilyl)-2',3'-bis-O-(trimethylsilyl)-
|
54623-28-8 |
2 | 4.774 |
|
« Previous Results
Next Results »
|